Tagworks Pharmaceuticals Announces $65 Million in Series A Financing led by Ysios Capital and Gilde Healthcare, to Advance Click-to-Release Therapeutics

by Ysios Capital

Tagworks Pharmaceuticals, the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $65 million Series A financing led by Ysios Capit...

Read more

OneChain Immunotherapeutics secures €6.7M in pre-series A funding round led by Invivo Capital

by Invivo Capital

The transaction was led by the venture capital firm Invivo Capital, with the participation of the current investors, the Josep Carreras Leukemia Foundation and the Centre for Technological Development...

Read more

Stirling Square portfolio company Sustainable Agro Solutions announces the acquisition of Biovert

by Professional Newco

Stirling Square Capital Partners has announced that its portfolio company Sustainable Agro Solutions has acquired Biovert, a developer and producer of bio-stimulants, biocontrol and specialty plant nu...

Read more

Orikine Bio closes €5.5m Series Seed Financing with Sabadell Asabys and AdBio

by Asabys Partners

Orikine Bio, a biotech company developing a novel proprietary platform for cytokine-based therapies for autoimmune and inflammatory diseases, announces today the successful closing of a €5.5m seed f...

Read more

Moira Capital e Inbergune adquieren el 30% de CIMICO, biotecnológica vasca líder en la innovación del tratamiento biológico de aguas residuales

by Moira Capital Partners

Moira Capital, firma de inversión de capital privado, y la gestora vasca Inbergune, han adquirido el 30% de CIMICO, compañía que está liderando la innovación en soluciones biotecnológicas para e...

Read more

Oportunidades de inversión en el sector farmacéutico en tiempos post-Covid

by BEKA Finance

Tras la lucha contra el Covid-19, las farmacéuticas se enfrentan a una nueva normalidad repleta de oportunidades y desafíos, y el mercado está listo para aprovecharlas. El reciente anuncio de que E...

Read more

Patia, a company owned by Talde and the Carlos Slim Foundation, gives the Basque Government a stake in its capital

by TALDE GESTIÓN, S.G.E.I.C., S.A.

The Basque Government, through Gestión de Capital Riesgo del País Vasco SGEIC, has formalized its entry into the biotech company Patia Diabetes with the aim of promoting research and development of ...

Read more

Alantra Private Equity portfolio company Health in Code acquires Genologica

by Alantra

Health in Code, a leading clinical genetic diagnostics company in Spain and an Alantra Private Equity portfolio company, has acquired genetic analysis laboratory Genologica to consolidate its leading ...

Read more

AbilityPharma will secure 7 million euros with a collective investment campaign in Capital Cell of up to 2 million to finance itself until the results of its international phase 2b study in pancreatic cancer

by Capital Cell

The Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes a collective investment campaign of up to 2 million on the Capital C...

Read more

Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys

by Asabys Partners

Asabys Partners led the round through its new fund Sabadell Asabys II and was joined by Thuja Capital and founding investor Sofinnova Partners. Gradient was established in 2020 through a €3.5m seed ...

Read more

ICF invests €10M in Asabys fund II, which has already 3 companies in its portfolio

by Institut Català de Finances (ICF)

​Asabys has announced that the Institut Català de Finances (ICF) has joined its new venture capital fund, Sabadell Asabys Health Innovation Investments II (Sabadell Asabys II), with 10 million euro...

Read more

AbolerIS Pharma Announces €27 Million in Series A Financing led by Caixa Capital Risc to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases

by Caixa Capital Risc

AbolerIS Pharma, a Belgian biopharmaceutical company developing an entirely novel approach to the treatment of chronic autoimmune and inflammatory diseases, today announced a €27.3 million Series A ...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra Private Equity strengthens AIVOR...

by Alantra

AIVORIQ has grown significantly since Alantra PE launched the project....

Photos Stream